title: Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.
abstract: Intermittent preventive treatment of malaria in pregnancy is a highly cost-effective intervention which significantly improves maternal and birth outcomes among mothers and their newborns who live in areas of moderate to high malaria transmission. However, coverage in sub-Saharan Africa remains unacceptably low, calling for urgent action to increase uptake dramatically and maximize its public health impact. The 'Global Call to Action' outlines priority actions that will pave the way to success in achieving national and international coverage targets. Immediate action is needed from national health institutions in malaria-endemic countries, the donor community, the research community, members of the pharmaceutical industry and private sector, along with technical partners at the global and local levels, to protect pregnant women and their babies from the preventable, adverse effects of malaria in pregnancy.
authors.affiliation: Department of Disease Control, London School of Tropical Medicine and Hygiene, London, UK. Matthew.Chico@lshtm.ac.uk.
authors.forename: R Matthew
authors.initials: RM
authors.lastname: Chico
authors.affiliation: Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. Stephanie.Dellicour@lstmed.ac.uk.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Dellicour
authors.affiliation: Maternal and Child Health Integrated Program, Jhpiego, Baltimore, MD, USA. Elaine.Roman@jhpiego.org.
authors.forename: Elaine
authors.initials: E
authors.lastname: Roman
authors.affiliation: RMNCH and HSS Technical Advice & Partnerships Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Vernier, Geneva, Switzerland. Viviana.Mangiaterra@theglobalfund.org.
authors.forename: Viviana
authors.initials: V
authors.lastname: Mangiaterra
authors.affiliation: Maternal and Child Health Integrated Program, Jhpiego, Baltimore, MD, USA. Jane.Coleman@jhpiego.org.
authors.forename: Jane
authors.initials: J
authors.lastname: Coleman
authors.affiliation: ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. menendez@clinic.ub.es.
authors.forename: Clara
authors.initials: C
authors.lastname: Menendez
authors.affiliation: Access & Product Management, Medicine for Malaria Venture, Geneva, Switzerland. majeresm@mmv.org.
authors.forename: Maud
authors.initials: M
authors.lastname: Majeres-Lugand
authors.affiliation: Department of Disease Control, London School of Tropical Medicine and Hygiene, London, UK. Jayne.Webster@lshtm.ac.uk.
authors.forename: Jayne
authors.initials: J
authors.lastname: Webster
authors.affiliation: Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. Jenny.Hill@lstmed.ac.uk.
authors.forename: Jenny
authors.initials: J
authors.lastname: Hill
mesh_terms: D017954:Africa South of the Sahara; D000962:Antimalarials / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D011634:Public Health; D014330:Tropical Medicine
chemical_list: D000962:Antimalarials